Effect of inhaled nitric oxide on pulmonary function in cystic fibrosis

Respiratory Medicine

Volumn 93, Issue 8, 1999, Pages 579-583

  Ratjen, F ^a   Gartig S ^a   Wiesemann, H G ^a   Grasemann, H ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NITRATE; NITRIC OXIDE; NITRITE;

ADOLESCENT; ADULT; ARTICLE; BRONCHUS TONE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; OXYGEN SATURATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SIDE EFFECT; SPIROMETRY; SPUTUM ANALYSIS;

EID: 0032831303     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(99)90158-0     Document Type: Article

References (27)

1. Konstan MW, Hilliard KA, Norvell T, Berger M. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 1994; 150: 448-454.
2. Grasemann H, Michler E, Wallot M, Ratjen F. Decreased concentrations of exhaled nitric oxide in patients with cystic fibrosis. Pediatr Pulmonol 1997; 24: 173-177.
3. Balfour-Lynn IM, Laverty A, Dinwiddie R. Reduced upper airway nitric oxide in cystic fibrosis. Arch Dis Child 1996; 75: 319-322.
4. Kelley TJ, Drumm ML. Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. J Clin Invest 1998; 102: 1200-1207.
5. Meng QH, Springall DR, Bishop AE, Morgan K, Evans TJ, Habib S, Gruenert DC, Gyi KM, Hodson ME, Yacoub MH, Polak JM. Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis. J Pathol 1998; 184: 323-331.
6. Belvisi MG, Ward JK, Mitchell JA, Barnes PJ. Nitric oxide as a neurotransmitter in human airways. Arch Int Pharmocodyn 1995; 329: 97-110.
7. Jain B, Lubinstein I, Robbins RA, Leise KL, Sisson JH. Modulation of airway epithelial cell ciliary beat frequency by nitric oxide. Biochem Biophys Res Commun 1993; 191: 83-88.
8. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of neutrophil adhesion. Proc Natl Acad Sci USA 1991; 88: 4651-4655.
9. Malawista SE, Montgomery RR, van Blarimcom G. Evidence for reactive intermediates in killing of staphylococci by human neutrophil cytoplasts. J Clin Invest 1992; 90: 631-636.
10. Belenky S, Robbins RA, Rennard SI, Gossman R, Nelson KJ, Rubinstein I. Inhibitors of nitric oxide synthase attenuate neutrophil chemotaxis in vitro. J Lab Clin Med 1993; 122: 388-394.
11. Furchtgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376.
12. Palmer RM, Ferrige AG, Mancada S. Nitric oxide release accounts for the biological activity of endothelial derived relaxing factor. Nature 1987; 327: 524-526.
13. Högman M, Frostell CG, Hedenström H, Hedenstierna G. Inhalation of nitric oxide modulates adult human bronchial tone. Am Rev Respir Dis 1993; 148: 1474-1478.
14. Lundberg JON, Settergren G, Gelinder S, Lundberg JM, Alving K, Weitzberg E. Inhalation of nasally derived nitric oxide modulates pulmonary function in humans. Acta Physiol Scand 1996; 158: 343-347.
15. Grasemann H, Ioannidis I, Tomkiewicz RP, de Groot H, Rubin BK, Ratjen F. Nitric oxide metabolites in cystic fibrosis lung disease. Arch Dis Child 1998; 78: 49-53.
16. Grasemann H, Gaertig SS, Wiesemann HG, Teschler H, Konietzko N, Ratjen F. Effect of L-arginine infusion on airway NO in cystic fibrosis and primary ciliary dyskinesia syndrome. Eur Respir J 1999; 13: 114-118.
17. Dupuy PM, Shore SA, Drazen JM, Frostell C, Hill WA, Zapol WM. Bronchodilator action of inhaled nitric oxide in guinea pigs. J Clin Invest 1992; 90: 421-428.
18. Högman M, Frostell CG, Arnberg H. Hedenstierna G. Inhalation of nitric oxide modulates metacholine-induced bronchoconstriction in the rabbit. Eur Respir J 1993; 6: 177-180.
19. Frostell C, Fratacci MD, Wain JC, Jonas R, Zapol WM. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991; 83: 2038-2047.
20. Katayama Y, Higenbottam W, Diaz de Atauri MJ, Cremona G, Akamine S, Barbera JA, Rodriguez-Roisin R. Inhaled nitric oxide and arterial oxygen tension in patients with chronic obstructive pulmonary disease and severe pulmonary hypertension. Thorax 1997; 52: 120-124.
21. Foubert L, Fleming B, Latimer R, Jonas M, Oduro A, Borland C, Higenbottam T.Safety guidelines for use of nitric oxide. Lancet 1992; 339: 1615-1616.
22. Edwards AD. The pharmacology of inhaled nitric oxide. Arch Dis Child 1993; 72: F127-F130.
23. Gaston B, Drazen JM, Loscalzo J, Stamler JS. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med 1994; 149: 538-551.
24. Worlitzsch D, Meyer KC, Birrer P, Doring G. Assessing oxygen: a bronchoscopic view into sputum plugged cystic fibrosis airways. 22. European CF Conference, Berlin 1998: 137A.
25. Nathan CF, Hibbs JB. The role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991; 3: 65-70.
26. Dong YJ, Chao AC, Kouyama K, Hsu YP, Bocian RC, Moss RB, Gardner P. Activation of CFTR chloride current by nitric oxide in human T lymphocytes EMBO J 1995; 14: 2700-2707.
27. Kamosinska B, Radomski MW, Duszyk M, Radomski A, Man SF. Nitric oxide activates chloride current in human lung epithelial cells Am J Physiol 1997; 272: L1098-L1104.